These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35063448)

  • 1. Risk of Cardiovascular Toxicity According to Tumor Laterality Among Older Patients With Early Stage Non-small Cell Lung Cancer Treated With Radiation Therapy.
    Liu BY; Rehmani S; Kale MS; Marshall D; Rosenzweig KE; Kong CY; Wisnivesky J; Sigel K
    Chest; 2022 Jun; 161(6):1666-1674. PubMed ID: 35063448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm.
    Tran JH; Mhango G; Park HS; Marshall DC; Rosenzweig KE; Wang Q; Wisnivesky JP; Veluswamy RR
    Clin Lung Cancer; 2023 Jan; 24(1):e9-e18. PubMed ID: 36443153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.
    Nyman J; Hallqvist A; Lund JÅ; Brustugun OT; Bergman B; Bergström P; Friesland S; Lewensohn R; Holmberg E; Lax I
    Radiother Oncol; 2016 Oct; 121(1):1-8. PubMed ID: 27600155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes.
    Appel S; Bar J; Ben-Nun A; Perelman M; Alezra D; Urban D; Ben-Ayun M; Honig N; Ofek E; Katzman T; Onn A; Chatterji S; Dubinski S; Tsvang L; Felder S; Kraitman J; Haisraely O; Rabin Alezra T; Lieberman S; Marom EM; Golan N; Simansky D; Symon Z; Lawrence YR
    Br J Radiol; 2019 May; 92(1097):20180960. PubMed ID: 30864828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
    Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
    JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.
    Harris JP; Murphy JD; Hanlon AL; Le QT; Loo BW; Diehn M
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):872-84. PubMed ID: 24495591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.
    Hsia TC; Tu CY; Chen HJ; Chen SC; Liang JA; Chen CY; Wang YC; Chien CR
    Anticancer Res; 2014 Sep; 34(9):5175-80. PubMed ID: 25202111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer.
    Mix M; Tanny S; Nsouli T; Alden R; Chaudhari R; Kincaid R; Rosenbaum PF; Bogart JA; Aridgides P
    Lung Cancer (Auckl); 2019; 10():151-159. PubMed ID: 31908556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease.
    Wang W; Huang L; Jin JY; Pi W; Ellsworth SG; Jolly S; Mellor AL; Machtay M; Kong FS
    Clin Cancer Res; 2020 Jan; 26(1):282-289. PubMed ID: 31471311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
    Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Klement RJ; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
    Int J Cancer; 2021 Jul; 149(2):358-370. PubMed ID: 33682927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.
    Shirvani SM; Juloori A; Allen PK; Komaki R; Liao Z; Gomez D; O'Reilly M; Welsh J; Papadimitrakopoulou V; Cox JD; Chang JY
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):139-47. PubMed ID: 23920393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.
    Shirvani SM; Jiang J; Gomez DR; Chang JY; Buchholz TA; Smith BD
    Lung Cancer; 2013 Nov; 82(2):252-9. PubMed ID: 24018022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell Lung Cancer.
    Yu B; Jun Ma S; Waldman O; Dunne-Jaffe C; Chatterjee U; Turecki L; Gill J; Yendamuri K; Iovoli A; Farrugia M; Singh AK
    JAMA Netw Open; 2022 Sep; 5(9):e2230704. PubMed ID: 36074462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
    Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
    Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques.
    Jairam V; Pasha S; Soulos PR; Gross CP; Yu JB; Park HS; Decker RH
    Lung Cancer; 2021 Nov; 161():171-179. PubMed ID: 34607209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
    Liao ZX; Komaki RR; Thames HD; Liu HH; Tucker SL; Mohan R; Martel MK; Wei X; Yang K; Kim ES; Blumenschein G; Hong WK; Cox JD
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):775-81. PubMed ID: 19515503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.
    Hu X; He W; Wen S; Feng X; Fu X; Liu Y; Pu K
    PLoS One; 2016; 11(4):e0151988. PubMed ID: 27100968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.
    Yu JB; Soulos PR; Cramer LD; Decker RH; Kim AW; Gross CP
    Cancer; 2015 Jul; 121(14):2341-9. PubMed ID: 25847699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.